PATH insider sale: 45,000 shares; ownership 29,693,585 after trade

Q: What did UiPath (PATH) disclose in this Form 4?

An insider who is the CEO and Chairman sold 45,000 Class A shares on 10/23/2025 under a Rule 10b5-1 plan.

Q: At what price were PATH shares sold in the reported transaction?

The average price was $15.1853 , with a $15.0000–$15.3300 range.

Q: How many PATH shares does the insider own after the sale?

Beneficial ownership after the sale is 29,693,585 shares directly and 240,000 shares indirectly by spouse.

Q: What is the transaction date for the PATH insider sale?

The transaction date is 10/23/2025 .

Q: Was the PATH insider trade made under a 10b5-1 plan?

Yes. The sale was made pursuant to a Rule 10b5-1 qualified selling plan.

Q: What roles does the reporting person hold at UiPath (PATH)?

The reporting person is listed as Director , CEO and Chairman , and a 10% Owner .

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

UiPath (PATH) reported an insider transaction by its CEO and Chairman. On 10/23/2025, the reporting person sold 45,000 Class A shares at an average price of $15.1853, with a range of $15.0000–$15.3300, pursuant to a Rule 10b5-1 plan. Following the sale, beneficial ownership stood at 29,693,585 shares directly and 240,000 shares indirectly by spouse.

Insider Trade Summary

Net Seller: 45,000 shares ($683,339)

Net Sell 2 txns

Insider Dines Daniel

Role CEO and Chairman

Sold 45,000 shs ($683K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	45,000	$15.1853	$683K
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 29,693,585 shares (Direct); Class A Common Stock — 240,000 shares (Indirect, by Spouse)

Footnotes (1)

These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The range of prices for the transactions reported was from $15.0000 to $15.3300. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Form 4 Insider Transactions: What Each Field Means →

10/23/2025 - 09:40 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dines Daniel

(Last)

(First)

(Middle)

C/O UIPATH, INC., ONE VANDERBILT AVENUE

60TH FLOOR

(Street)

NEW YORK

10017

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Chairman

3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	10/23/2025		S		45,000⁽¹⁾	D	$15.1853⁽²⁾	29,693,585	D
Class A Common Stock								240,000	I	by Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.

2. The range of prices for the transactions reported was from $15.0000 to $15.3300. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

Remarks:

	/s/ Brad Brubaker, Attorney-in-Fact	10/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did UiPath (PATH) disclose in this Form 4?

An insider who is the CEO and Chairman sold 45,000 Class A shares on 10/23/2025 under a Rule 10b5-1 plan.

At what price were PATH shares sold in the reported transaction?

The average price was $15.1853, with a $15.0000–$15.3300 range.

How many PATH shares does the insider own after the sale?

Beneficial ownership after the sale is 29,693,585 shares directly and 240,000 shares indirectly by spouse.

What is the transaction date for the PATH insider sale?

The transaction date is 10/23/2025.

Was the PATH insider trade made under a 10b5-1 plan?

Yes. The sale was made pursuant to a Rule 10b5-1 qualified selling plan.

What roles does the reporting person hold at UiPath (PATH)?

The reporting person is listed as Director, CEO and Chairman, and a 10% Owner.